Aurinia Pharmaceuticals AUPH Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's total costs & expenses?
- Aurinia Pharmaceuticals (AUPH) reported total costs & expenses of $36.28M in Q1 2026.
- How has Aurinia Pharmaceuticals's total costs & expenses changed year-over-year?
- Aurinia Pharmaceuticals's total costs & expenses decreased by 10.7% year-over-year, from $40.62M to $36.28M.
- What is the long-term trend for Aurinia Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's total costs & expenses has grown at a -5.8% compound annual growth rate (CAGR), from $226.34M to $178.14M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to generate revenue and maintain business operations during a specific period. It encompasses cost of goods sold, research and development expenditures, and selling, general, and administrative expenses. Monitoring this figure allows stakeholders to evaluate the company's overall cost structure and operational efficiency relative to its revenue generation.